结核病预防治疗的3HP疗法:在印度等国家大规模实施期间的安全性,剂量和相关问题
Anurag Bhargava1,2,3
1Department of Medicine, Yenepoya Medical College, Mangalore, Karnataka, India.
The Lancet regional health. Southeast Asia
|February 17, 2025
概括
为期3个月的每周一次的异化-利法丁 (3HP) 疗法用于预防结核病显示出有前途,但存在系统性药物反应的风险,特别是在体重较低的个体中. 推基于体重的剂量和皮里多克素的同时使用,以确保更安全的实施.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 世界卫生组织推为期3个月的每周一次的异化-利法丁 (3HP) 方案用于结核病预防治疗.
- 虽然3HP提供了较高的完成率和较低的肝毒性比异化预防性治疗,但它与增加的全身药物反应 (SDRs) 有关.
研究的目的:
- 评估3HP疗程的安全性,特别是亚洲地区的系统性药物反应.
- 确定风险因素,并提出减轻与3HP治疗相关的不良事件的策略.
主要方法:
- 在亚洲人群中对3HP治疗方案的可用安全数据的审查.
- 报告的不良事件的分析,包括全身药物反应 (SDR) 和3级或4级事件.
- 检查药物动力学数据和潜在的促成因素,如体重指数 (BMI) 和乙化剂状态.
主要成果:
- 来自亚洲地区的有限而异质的安全数据表明,3HP的SDR的频率更高.
- 在19%的家庭接触者中报告了头,该家庭接触者在德里的3HP上开始接触.
- 系统性药物反应 (SDR) 可能与异化的血度有关,固定的剂量方案对体重较低的个体构成风险.
结论:
- 由于亚洲人群中SDR的频率较高,大规模实施3HP方案需要谨慎.
- 基于体重的异化剂量,同时服用氧化和强有力的药物监测对于安全推出3HP至关重要.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.8K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.7K
相关概念视频
Pulmonary Tuberculosis V
168
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
168
Pulmonary Tuberculosis IV
128
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
128
Pulmonary Tuberculosis I
218
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
218
Pulmonary Tuberculosis III
293
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
293
Pulmonary Tuberculosis II
210
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
210
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
